Hepatic adverse drug reactions in Malaysia: An 18-year review of the national centralized reporting system.

Fei Yee LeeHin-Seng WongHuan-Keat ChanNorleen Mohamed AliMuhammad Radzi Abu HassanHaniza OmarNoor Aliza Abdul Mutalib

Published in: Pharmacoepidemiology and drug safety (2020)

Hepatic ADR cases have increased significantly in Malaysia, with antituberculosis drugs, systemic antibacterials, and TCM/HDS being the most common causative agents reported. Most TCM/HDS reported to be associated with hepatic ADR were not registered with the authorities.

Keyphrases

adverse drug
electronic health record
drug induced
emergency department
quality improvement